Serum cholesterol levels and postoperative atrial fibrillation

Journal of Cardiothoracic Surgery

Volumn 9, Issue 1, 2014, Pages

  Aydin, Mehmet ^a   Susam, Ibrahim ^a   Kilicaslan, Baris ^a,d   Dereli, Münevver ^b   Sacar, Mustafa ^c   Ozdogan, Oner ^a  

^a Tepecik Research and Training Hospital ^*  (Turkey)

^b AFYON KOCATEPE UNIVERSITY   (Turkey)

^c ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

^d NONE   (Turkey)

Author keywords

Arterial fibrillation; Coronary artery bypass; Electrocardiography; Hypercholesterolemia; Lipoproteins

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ATRIAL FIBRILLATION; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; COMPLICATION; CORONARY ARTERY BYPASS GRAFT; FEMALE; HUMAN; HYPERLIPOPROTEINEMIAS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, LDL; CORONARY ARTERY BYPASS; FEMALE; HUMANS; HYPERLIPOPROTEINEMIAS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE PERIOD; PROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES;

EID: 84939425138     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-9-69     Document Type: Article

References (24)

1. Renato JA, Rodrigo NC, Kenji N: Choronic and regular use of statin prevents atrial fibrillation in period after cardiac surgery. Arq Bras Cardiol 2010, 95(5):614-620.
2. Cox JL: A perspective of postoperative atrial fibrillation in cardiac operations. Ann Thorac Surg 1993, 56(3):405-409.
3. Brugada R, Tapscott T, Czernuszewicz GZ, Marian AJ, Iglesias A, Mont L, Brugada J, Gona J, Domingo A, Bachinski LL, Roberts R: Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997, 336(13):905-911.
4. Patti G, Chello M, Candura D, Pasceri V, D'Ambrosio A, Covino E, Di Sciascio G: Randomized trial of atorvastatin for reduction of post operative atrial fibrillation in patients undergoing cardiac surgery. results from the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhyhmias After cardiac surgery) study. Circulation 2006, 114(14):1455-1461.
5. Ommen SR, Odell JA, Stanton MS: Atrial arrhythmias after cardiothoracic surgery. N Engl J Med 1997, 336(20):1429-1434.
6. Oral H: Post-operative atrial fibrillation and oxidative stress: a novel causal mechanism or another biochemical epiphenomenon? J Am Coll Cardiol 2008, 51(1):75-76.
7. Bradley D, Creswell LL, Hogue CW Jr, Epstein AE, Prystowsky EN, Daoud EG, American College of Chest Physicians: Pharmacologic prophylaxis: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 2005, 128(2 Suppl):39S-47S.
8. Gaudino M, Andreotti F, Zamparelli R, Di Castelnuovo A, Nasso G, Burzotta F, Iacoviello L, Donati MB, Schiavello R, Maseri A, Possati G: The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation 2003, 108(Suppl 1):II195-II199.
9. Liu YB, Wu CC, Lee CM, Chen WJ, Wang TD, Chen PS, Lee YT: Dyslipidemia is associated with ventricular tachyarrhythmia in patients with acute ST-segment elevation myocardial infarction. J Formos Med Assoc 2006, 105(1):17-24.
10. Young-Xu Y, Jabbour S, Goldberg R, Blatt CM, Graboys T, Bilchik B, Ravid S: Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol 2003, 92(12):1379-1383.
11. Saini HK, Arneja AS, Dhalla NS: Role of cholesterol in cardiovascular dysfunction. Can J Cardiol 2004, 20(3):333-346.
12. Bastiaanse EM, Höld KM, Van der Laarse A: The effect of membrane cholesterol content on ion transport processes in plasma membranes. Cardiovasc Res 1997, 33(2):272-283.
13. Yeagle PL: Lipid regulation of cell membrane structure and function. FASEB J 1989, 3(7):1833-1842.
14. Shiroshita-Takeshita A, Brundel BJ, Nattel S: Atrial fibrillation: basic mechanisms, remodeling and triggers. J Interv Card Electrophysiol 2005, 13(3):181-193.
15. Boos CJ, Anderson RA, Lip GY: Is atrial fibrillation an inflammatory disorder? Eur Heart J 2006, 27(2):136-149. Epub 2005 Nov 8.
16. Bruins P, te Velthuis H, Yazdanbakhsh AP, Jansen PG, van Hardevelt FW, de Beaumont EM, Wildevuur CR, Eijsman L, Trouwborst A, Hack CE: Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997, 96(10):3542-3548.
17. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, Bauer JA, Tchou PJ, Niebauer MJ, Natale A, Van Wagoner DR: C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001, 104(24):2886-2891.
18. Nattel S: Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation. Cardiovasc Res 1999, 42(2):298-308.
19. Dotani MI, Elnicki DM, Jain AC, Gibson CM: Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. Am J Cardiol 2000, 86(10):1128-1130. A6.
20. Ozaydin M, Dogan A, Varol E, Kapan S, Tuzun N, Peker O, Aslan SM, Altinbas A, Ocal A, Ibrisim E: Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation. Cardiology 2007, 107(2):117-121.
21. Cooper RA, Sawyer WH, Leslie MH, Hill JS, Gill FM, Wiley JS: Normal fluidity of red cell membranes in hereditary spherocytosis. Br J Haematol 1980, 46(2):299-301.
22. Tesfamariam B, Frohlich BH, Gregg RE: Differential effects of pravastatin, simvastatin, and atorvastatin on Ca2+ release and vascular reactivity. J Cardiovasc Pharmacol 1999, 34(1):95-101.
23. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T: Single LDL apharesis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 1997, 95(1):76-82.
24. Mellwig KP, Baller D, Gleichmann U, Moll D, Betker S, Weise R, Notohamiprodjo G: Improvement of coronary vasodilatation capacity through single LDL apheresis. Atherosclerosis 1998, 139(1):173-178.